# TELI COM - Telithromycin in Children With Otitis Media

> **NCT00315003** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 1500 (—)

## Conditions studied

- Otitis Media, Suppurative
- Otitis Media, Purulent

## Interventions

- **DRUG:** Telithromycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00315003
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 1500 (—)
- **Why stopped:** Pediatric development program terminated by sponsor
- **Last updated:** 2009-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315003, "TELI COM - Telithromycin in Children With Otitis Media". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00315003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*